Pediatrix Medical Group, Inc. has announced its financial results for the third quarter of 2026, providing insights into its operational performance and future outlook.

Background

Pediatrix Medical Group, Inc., a Florida corporation, specializes in healthcare services under the SIC classification of 8060, Services-Hospitals. The company trades under the ticker symbol MD on the New York Stock Exchange. Recent filings include an 8-K on October 29, 2026, detailing the latest financial results.

What the Filing Says

In its latest filing, Pediatrix reported, "On October 29, 2026, Pediatrix Medical Group, Inc. issued a press release announcing the results of its operations for the three and nine months ended September 30, 2026." The detailed financial results are included in the attached Exhibit 99.1.

Impact

This update is significant for various stakeholders, including investors, healthcare providers, and industry analysts. As Pediatrix continues to navigate the healthcare landscape, its financial performance may influence market perceptions and competitive strategies within the services-hospitals sector.

What's Next

The filing does not say what happens next.

Financial Highlights

The filing indicates that Pediatrix Medical Group, Inc. reported its operational results for the three and nine months ended September 30, 2026. The detailed financial performance is elaborated in the attached Exhibit 99.1, which includes metrics such as revenue, net income, and earnings per share.

Company Information

Pediatrix Medical Group, Inc. is incorporated in Florida and has a Central Index Key (CIK) of 0000893949. The company operates under the SEC file number 001-12111 and has a fiscal year that ends on December 31.

Contact Information

The company's principal executive offices are located at 1301 Concord Terrace, Sunrise, Florida, 33323. For inquiries, the business phone number is 954-384-0175.

Exhibits

The filing includes an exhibit index, with Exhibit 99.1 being the press release detailing the financial results for the third quarter. Additionally, it mentions an embedded cover page interactive data file (104) within the Inline XBRL document.

Emerging Growth Company Status

The filing confirms that Pediatrix Medical Group, Inc. has not elected to be treated as an emerging growth company as defined under the Securities Act of 1933 and the Securities Exchange Act of 1934.